4//SEC Filing
D'Angio Paul 4
Accession 0001209191-23-023683
CIK 0001538210other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 8:36 PM ET
Size
22.1 KB
Accession
0001209191-23-023683
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
D'Angio Paul
Director
Transactions
- Award
Stock Option (right to buy)
2023-04-04+23,122→ 23,122 totalExercise: $1.64Exp: 2029-03-18→ Common Stock (23,122 underlying) - Disposition to Issuer
Stock Option (right to buy)
2023-04-04−12,634→ 0 totalExercise: $2.42Exp: 2037-03-02→ Common Stock (12,634 underlying) - Disposition to Issuer
Stock Option (right to buy)
2023-04-04−61,678→ 0 totalExercise: $1.82Exp: 2032-06-12→ Common Stock (61,678 underlying) - Disposition to Issuer
Stock Option (right to buy)
2023-04-04−9,556→ 0 totalExercise: $17.00Exp: 2031-02-10→ Common Stock (9,556 underlying) - Award
Stock Option (right to buy)
2023-04-04+61,678→ 61,678 totalExercise: $1.64Exp: 2032-06-12→ Common Stock (61,678 underlying) - Award
Stock Option (right to buy)
2023-04-04+9,556→ 9,556 totalExercise: $1.64Exp: 2031-02-10→ Common Stock (9,556 underlying) - Disposition to Issuer
Stock Option (right to buy)
2023-04-04−23,122→ 0 totalExercise: $4.31Exp: 2029-03-18→ Common Stock (23,122 underlying) - Award
Stock Option (right to buy)
2023-04-04+12,634→ 12,634 totalExercise: $1.64Exp: 2037-03-02→ Common Stock (12,634 underlying)
Footnotes (4)
- [F1]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. D'Angio's continued service on such vesting date.
- [F2]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested.
- [F3]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 19, 2019, of which all of the shares subject to such option have vested.
- [F4]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 3, 2017, of which all of the shares subject to such option have vested.
Documents
Issuer
NexImmune, Inc.
CIK 0001538210
Entity typeother
Related Parties
1- filerCIK 0001843748
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 8:36 PM ET
- Size
- 22.1 KB